Institutional Ownership
Tempest Therapeutics Inc
CUSIP 87978U207COM NEWTPSTQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
35.9%
Max % of class reported
Institutional Holders
18
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Feb 10, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 87.0K | $142.7K |
| 2 | Blackrock, Inc. | 39.1K | $64.1K |
| 3 | Fmr LLC | 33.2K | $54.5K |
| 4 | Sabby Management, LLC | 17.9K | $29.3K |
| 5 | Northern Trust Corp | 14.1K | $23.0K |
| 6 | Dimensional Fund Advisors LP | 11.4K | $18.8K |
| 7 | Ubs Group AG | 4.5K | $7.4K |
| 8 | Tower Research Capital LLC (Trc) | 2.8K | $4.6K |
| 9 | Morgan Stanley | 2.1K | $3.4K |
| 10 | Osaic Holdings, Inc. | 1.5K | $2.5K |